UCSF 33rd Annual Rheumatology Board Review & Clinical Update – 2025

UCSF Rheumatology Board Review & Clinical Update – 2025

Date & Format

• August 21–23, 2025
  

Overview
This is the 33rd Annual Rheumatology Board Review, a hybrid continuing medical education (CME) course presented by UCSF. Designed for physicians preparing for the ABIM Rheumatology Subspecialty Exam and those seeking to stay updated in clinical rheumatology, the course provides practice-changing updates and diagnostic guidance.

Learning Objectives

By the end of the course, participants will be able to:

1. Apply evidence-based standards of care across disorders like rheumatoid arthritis, lupus, osteoarthritis, osteoporosis, seronegative arthritis, autoinflammatory diseases, and soft tissue syndromes

2. Enhance diagnostic accuracy using the latest clinical data and expert recommendations

3. Optimize and monitor treatment plans based on current evidence of efficacy and safety

4. Appropriately integrate newly approved rheumatology therapies

5. Improve pain management strategies per latest guidelines

6. Increase the use of self-assessment tools in clinical practice
   

Topics Covered (Sample from Previous Years)

While the full 2025 program will likely mirror prior editions, expected key topics include:

• Systemic Lupus Erythematosus

• Myositis & Mimics

• Osteoporosis Prevention & Treatment

• Rheumatoid Arthritis Epidemiology & Complications

• Autoinflammatory Diseases

• Imaging Interpretation in Rheumatology

Course Outline